Streetbeat News

Stock Prices

ZETA

Zeta Global Holdings (NYSE:ZETA) reported Q4 earnings with an EPS of $-0.22, missing estimates by -257.0% against an expected $0.14. Revenue increased by $35.18 million from the previous year. Despite past earnings misses, the company's share price increased by 5.0% the day after last quarter's earnings were announced.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:15 pm

PGNY

Progyny (NASDAQ:PGNY) reported Q4 earnings with a 30.0% beat on estimated EPS, reporting $0.13 versus an estimate of $0.1. Revenue increased by $55.62 million from the same period last year. Despite beating last quarter's EPS estimate, the share price dropped by 8.0% the following day. Historical earnings show consistent beats on EPS estimates.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:15 pm

SPLK

Splunk (NASDAQ:SPLK) reported Q4 2024 adjusted EPS of $3.43, surpassing the $1.95 estimate, and sales of $1.49B, exceeding the $1.28B estimate. This represents a 68.14% increase in earnings and an 18.78% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:14 pm

PGNY

Progyny (NASDAQ:PGNY) reported Q4 2023 earnings of $0.13 per share, surpassing the $0.10 estimate, but its sales of $269.94M fell short of the $273.66M forecast. This represents a 25.95% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:14 pm

ACAD

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported Q4 2023 earnings of $0.28 per share, missing the consensus estimate of $0.31. However, their quarterly sales of $231.04 million exceeded the estimate of $223.79 million, marking a 69.27% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:13 pm

JAMF

Jamf shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:12 pm

DVN

Devon Energy (NYSE:DVN) reported Q4 sales of $4.14 billion, surpassing the analyst consensus estimate of $3.87 billion by 7.05%, but marking a 3.58% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:12 pm

XNCR

Xencor (NASDAQ:XNCR) reported Q4 2023 GAAP EPS of $(0.31), missing the $(0.09) estimate, with sales of $44.69M also missing the $73.84M estimate. Despite this, sales increased 106.80% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:12 pm

RSG

Republic Services (RSG) reported Q4 2023 adjusted EPS of $1.41, surpassing the $1.29 estimate, with sales of $3.83B exceeding the $3.73B forecast. This represents an 8.54% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:11 pm

AGL

Agilon Health's stock price has decreased following the announcement of its Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:11 pm